DNP 850B Module 4 The Intervention and Its Timeline Example

From Enrollment Visit to Week Twelve: The Nurse-Managed Home Blood Pressure Intervention, Step by Step

Student Name

Doctor of Nursing Practice Program, Aspen University

DNP 850B: Project Proposal

Instructor Name

Month Day, Year

From Enrollment Visit to Week Twelve: The Nurse-Managed Home Blood Pressure Intervention, Step by Step

An intervention section should be detailed enough that another nurse could deliver the same program without asking the author what was meant. This paper drafts that section for my DNP project at a community health center clinic, where two nurse care managers will take charge of what enrolled patients measure at home and change their treatment by protocol across 12 weeks. It describes staff preparation, the enrollment visit, the home reading schedule, the weekly review, the titration protocol, escalation, communication with clinicians and the end of the program, then sets out the timeline and the rules for adapting the intervention.

Staff Preparation

In the two weeks before enrollment begins, the nurse care managers will complete a four-hour session with the medical director on the protocol, including three practice cases, and will be signed off as competent to use it. Medical assistants will complete a one-hour session on standardized office measurement with a return demonstration. Front-desk staff and the community health worker will receive a brief orientation on how patients are identified and scheduled. A large health system's hypertension program found that standardized measurement by medical assistants and shared treatment algorithms were among the elements associated with its rise in control, which is why both groups are trained before any patient is enrolled (Jaffe et al., 2013).

The Enrollment Visit

Each enrolled patient will attend a 45-minute visit with a nurse care manager, in English or Spanish. The nurse will confirm eligibility, explain the program, fit the validated upper-arm cuff and check that the arm size matches it, and teach the measurement technique, asking the patient to demonstrate it back. Patients will be taught to take two readings a minute apart each morning before medication and each evening, on at least three days each week, following the procedure recommended in the national policy statement on self-measured monitoring (Shimbo et al., 2020). The nurse will set up portal transmission on the patient's phone or, for patients without one, arrange to receive readings by telephone each week. Every patient will leave with a written card stating when to call the clinic the same day, including any reading of 180/110 mm Hg or higher or symptoms such as chest pain or weakness.

Weekly Review and Titration

Each week, the nurse will calculate the patient's average home reading from all readings transmitted, discarding the first day's readings after any medication change. Home averages are judged against 135/85 mm Hg, the home value that the 2017 guideline pairs with an office reading of 140/90 (Whelton et al., 2018). If the weekly average is at or above the threshold and the patient reports taking medication as prescribed, the nurse will move one step in the protocol signed by the medical director. The steps increase an existing medication to its next dose or add a medication from a class recommended as first-line, in a set order, and they favor single-pill combinations where the patient's coverage allows. A basic metabolic panel is ordered one to two weeks after starting or increasing an agent that affects potassium or kidney function. If the average is below the threshold, the nurse confirms adherence, reinforces technique and makes no change.

The nurse will not titrate if the patient reports missed doses, side effects or recent illness; instead, the contact will focus on the reason, and the change will be reconsidered the following week. At most one medication change will be made each week, and no more than four over the program.

Escalation and Communication

Certain findings send the decision back to the patient's own clinician within the day: a home average below 100 mm Hg systolic, symptoms of low blood pressure, potassium over 5.5 mmol/L, creatinine rising of more than 30% from baseline, suspected pregnancy or any adverse reaction. Every nurse contact will be documented in the record's existing chronic care note, which routes to the patient's clinician. Clinicians keep the authority to change or stop any step, and their decision is recorded. Weekly, the nurses will send each clinician a short list of their enrolled patients with the latest average and any change made.

End of the Program

At week 12, each patient will have an office visit with a standardized reading taken by a trained medical assistant, which provides the primary outcome. Patients will then choose whether to continue home monitoring under usual care, with the cuff theirs to keep, and the nurse will write a handoff note summarizing the medication changes and the latest averages.

Timeline

The table sets out the timeline from preparation to closeout.

Adapting Without Losing the Core

The core of the intervention is fixed: validated home readings, a weekly nurse review, titration by the signed protocol and a documented handoff to clinicians. Its delivery can adapt. If patients struggle with the portal, readings may be reported by telephone; if the weekly review takes longer than planned, contacts may be grouped into a scheduled block; if a medication is unavailable at the patient's pharmacy, the protocol lists an alternative in the same class. Any adaptation will be recorded in the project log with its date and reason, so the results can be interpreted against what was actually delivered.

Conclusion

The intervention is a sequence with defined steps, thresholds and handoffs: trained staff, a structured enrollment visit, validated home readings, a weekly review against a guideline threshold, protocol titration with safety checks and a clear end. Describing it at this level allows the committee to judge its safety and the project to measure its fidelity.

References

Jaffe, M. G., Lee, G. A., Young, J. D., Sidney, S., & Go, A. S. (2013). Improved blood pressure control associated with a large-scale hypertension program. JAMA, 310(7), 699-705. https://doi.org/10.1001/jama.2013.108769

Shimbo, D., Artinian, N. T., Basile, J. N., Krakoff, L. R., Margolis, K. L., Rakotz, M. K., & Wozniak, G. (2020). Self-measured blood pressure monitoring at home: A joint policy statement from the American Heart Association and American Medical Association. Circulation, 142(4), e42-e63. https://doi.org/10.1161/CIR.0000000000000803

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Jr., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Sr., . . . Wright, J. T., Jr. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13-e115. https://doi.org/10.1161/HYP.0000000000000065